Skip to content

Clinical trials

Observational Mental Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Phase: Observational Country / region: Germany Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20141
20151
20171
20192
202011
20211
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status6
Suspended2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany10
Hannover Medical School1
Jacobs University Bremen gGmbH1
Max-Planck-Institute of Psychiatry1
Medizinische Hochschule Brandenburg Theodor Fontane1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Philipps University Marburg1
Semmelweis University1
Technische Universität Dresden1
University Hospital Heidelberg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders23
Anxiety Disorders5
Burnout, Professional3
COVID-192
Neoplasms2
Alzheimer Disease1
Carcinoma1
Claustrophobia1
Cognitive Dysfunction1
Dementia1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.